Pfizer’s Karen Reeves Joins AZTherapies as Chief Medical Officer

AZTherapies has appointed Karen Reeves chief medical officer. Reeves joins the Boston company from Pfizer (NYSE: [[ticker:PFE]]), where she held multiple senior leadership positions in research and development, and regulatory and safety. Before Pfizer, Reeves was head of global medical science at Astellas Pharma Global Development. AZTherapies develops treatments for Alzheimer’s disease, ischemic stroke, and other neurological diseases. The company’s lead drug candidate, ALZT-OP1, is an Alzheimer’s therapy that combines two re-engineered drugs. The combination therapy is in a Phase 3 study.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan